Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Agarwal

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|April 16, 2018
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetesSameer Agarwal, Santosh Sasane, Jeevan Kumar, et al.
Indian Journal of Endocrinology and Metabolism|November 13, 2025
Development and Implementation of a Nationwide Structured Education Programme for Type 1 Diabetes in India: The T1DE InitiativeRajiv Singla, Deep Dutta, Vineet Surana, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2020
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitorSameer Agarwal, Jignesh P Pethani, Hardik A Shah, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of a Potent and Orally Efficacious TGR5 Receptor AgonistSameer Agarwal, Amit Patil, Umesh Aware, et al.
Indian Journal of Endocrinology and Metabolism|May 30, 2017
Patient-centered Management of HypothyroidismSanjay Kalra, Navneet Agarwal, Rashmi Aggarwal, et al.
Indian Journal of Endocrinology and Metabolism|July 4, 2017
Medication Counseling for ThyroxineSanjay Kalra, A G Unnikrishnan, Mangesh Tiwaskar, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of <i>N</i>-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome InhibitorsSameer Agarwal, Santosh Sasane, Hardik A Shah, et al.
Urology|August 28, 2019
Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate CancerLuke C Peng, Omar Y Mian, Pranav Lakshminarayanan, et al.
Frontiers in Immunology|September 21, 2018
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane StructureJon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, et al.
Brain Research|July 29, 2024
A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's diseaseAbhijit Chatterjee, Jogeswar Mohapatra, Manoranjan Sharma, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|April 16, 2018
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetesSameer Agarwal, Santosh Sasane, Jeevan Kumar, et al.
Indian Journal of Endocrinology and Metabolism|November 13, 2025
Development and Implementation of a Nationwide Structured Education Programme for Type 1 Diabetes in India: The T1DE InitiativeRajiv Singla, Deep Dutta, Vineet Surana, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2020
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitorSameer Agarwal, Jignesh P Pethani, Hardik A Shah, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of a Potent and Orally Efficacious TGR5 Receptor AgonistSameer Agarwal, Amit Patil, Umesh Aware, et al.
Indian Journal of Endocrinology and Metabolism|May 30, 2017
Patient-centered Management of HypothyroidismSanjay Kalra, Navneet Agarwal, Rashmi Aggarwal, et al.
Indian Journal of Endocrinology and Metabolism|July 4, 2017
Medication Counseling for ThyroxineSanjay Kalra, A G Unnikrishnan, Mangesh Tiwaskar, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of <i>N</i>-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome InhibitorsSameer Agarwal, Santosh Sasane, Hardik A Shah, et al.
Urology|August 28, 2019
Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate CancerLuke C Peng, Omar Y Mian, Pranav Lakshminarayanan, et al.
Frontiers in Immunology|September 21, 2018
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane StructureJon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, et al.
Brain Research|July 29, 2024
A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's diseaseAbhijit Chatterjee, Jogeswar Mohapatra, Manoranjan Sharma, et al.
Pageof 2